Mavenclad (cladribine)
pCPA File Number:
23367
Negotiation Status:
Active Negotiation
Indication(s):
Multiple Sclerosis, Relapsing-Remitting
Sponsor/Manufacturer:
EMD Serono Canada, a division of EMD Inc.
CDA-AMC Project Number:
TS0004-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable